QUOTE AND NEWS
Motley Fool  3 hrs ago  Comment 
Does AbbVie's Humira-powered growth outweigh the potential for Eli Lilly's pipeline?
MarketWatch  4 hrs ago  Comment 
Eli Lilly & Co. and AstraZeneca Plc said Friday they have entered an agreement to jointly develop an Alzheimer's Disease treatment. The companies will work together on MEDI1814, an antibody selective for amyloid-beta 42, which is currently in...
Benzinga  7 hrs ago  Comment 
Eli Lilly and Company (NYSE: LLY) presented Thursday, detailed results of its phase 3 EXPEDITION3 trial at the 9th Clinical Trials on Alzheimer's Disease (CTAD) meeting. As previously disclosed, solanezumab did not meet the primary endpoint in the...
newratings.com  Dec 8  Comment 
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) said that the neoMONARCH study of abemaciclib, a cyclin-dependent kinase or CDK 4 and CDK 6 inhibitor, met its primary endpoint of reducing expression of Ki67, a biomarker of cell proliferation,...
Motley Fool  Dec 7  Comment 
Eli Lilly's Alzheimer’s program is a bust. Does the market’s overreaction make this Big Pharma stock more attractive than Johnson & Johnson's right now?
FierceBiotech  Dec 7  Comment 
Neurimmune, TVM set up ALS biotech, secure support of Eli Lilly unit for advance toward clinical proof of concept nick.paul.taylor Wed, 12/07/2016 - 07:27
newratings.com  Dec 5  Comment 
INDIANAPOLIS (dpa-AFX) - Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Co. (LLY) said that the U.S. Food and Drug Administration has approved a new indication for Jardiance or empagliflozin tablets to reduce the risk of...
Motley Fool  Dec 3  Comment 
The stock cratered after the drugmaker reported bummer news from an important late-stage clinical trial.
The Hindu Business Line  Dec 1  Comment 
Pharma major Lupin today announced a new partnership with Eli Lilly India to market and sell the latter’s diabetes treatment drug ‘Eglucent’ in the country. “According to the agreement, Lupin will ...
Forbes  Nov 30  Comment 
If the healthcare industry’s approach to Alzheimer’s disease were a building project, it could best be described as constructinga skyscraper from the top down--possible, yet at best impractical. Last week Eli Lilly and Company announced that...




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki